Related references
Note: Only part of the references are listed.Vascular Smooth Muscle Cell Peroxisome Proliferator-Activated Receptor-γ Mediates Pioglitazone-Reduced Vascular Lesion Formation
Milton Hamblin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase
Chi Yung Yuen et al.
CARDIOVASCULAR RESEARCH (2011)
Regulation of Endothelial Permeability via Paracellular and Transcellular Transport Pathways
Yulia Komarova et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
Bioinformatic Analysis of Gene Sets Regulated by Ligand-Activated and Dominant-Negative Peroxisome Proliferator-Activated Receptor γ in Mouse Aorta
Henry L. Keen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Pioglitazone-Induced Reductions in Atherosclerosis Occur via Smooth Muscle Cell-Specific Interaction With PPARγ
Venkateswaran Subramanian et al.
CIRCULATION RESEARCH (2010)
Immune and Inflammatory Mechanisms of Atherosclerosis
Elena Galkina et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Molecular mechanisms of endothelial hyperpermeability: implications in inflammation
Puneet Kumar et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Oxidized phospholipids in control of inflammation and endothelial barrier
Panfeng Fu et al.
TRANSLATIONAL RESEARCH (2009)
Fat and beyond: The diverse biology of PPAR gamma
Peter Tontonoz et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Peroxisome proliferator-activated receptor-γ-mediated effects in the vasculature
Sheng Zhong Duan et al.
CIRCULATION RESEARCH (2008)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Expression of Tie-2 by human monocytes and their responses to angiopoietin-2
Craig Murdoch et al.
JOURNAL OF IMMUNOLOGY (2007)
Nitric oxide activation of peroxisome proliferator-activated receptor gamma through a p38 MAPK signaling pathway
Anetta Ptasinska et al.
FASEB JOURNAL (2007)
Expression of peroxisome proliferator-activated receptor-γ in macrophage suppresses experimentally induced colitis
Yatrik M. Shah et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Endothelial injury in the initiation and progression of vascular disorders
Belay Tesfamariam et al.
VASCULAR PHARMACOLOGY (2007)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Conditional knockout of macrophage PPARγ increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice
VR Babaev et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
PPARγ in endothelial cells influences high fat diet-induced hypertension
CJ Nicol et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Apoptotic cell death in atherosclerosis
TD Littlewood et al.
CURRENT OPINION IN LIPIDOLOGY (2003)
Constitutive activation of peroxisome proliferator-activated receptor-γ suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells
NP Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats -: Role of peroxisome proliferator-activated receptor-γ
QN Diep et al.
CIRCULATION (2002)
Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux
TE Akiyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
A Chawla et al.
MOLECULAR CELL (2001)
Peroxisome proliferator-activate inhibit development of atherosclerosis in LDL receptor-deficient mice
AC Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
